Psychiatrist

  • Placeholder

    ALCOHOL (ETHANOL) SCREEN, SERUM

    0 out of 5

    Alcohol is a CNS depressant and excess can lead to intoxication and possibly death. Each ounce of whisky / wine increases blood alcohol by 15-25 mg / dL. Women absorb alcohol much more rapidly than men and show a 35- 45% higher blood alcohol levels. Blood alcohol level is a better indicator of intoxication or impairment.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    ALLERGY, GLUTEN (Lasa)

    0 out of 5
    • Pre-test Information:

      No special preparation required.

    • Report Delivery:

      Sample Daily by 11am; Report Same day

  • Placeholder

    AMITRIPTYLINE

    0 out of 5

    Amitriptyline is a tricyclic antidepressant that is metabolized to Nortriptyline which has same pharmacologic activity. This assay is useful for monitoring serum concentration during therapy, evaluating potential toxicity and patient compliance.

    • Pre-test Information:

      Recommended specimen: >12 hours post oral dose.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    AMPHETAMINE SCREEN, URINE

    0 out of 5

    Amphetamines are sympathomimetic amines that stimulate the CNS and supress appetite. They are a common cause of drug abuse. This assay confirms drug exposure of Amphetamines and its metabolites.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    BARBITURATE SCREEN, QUALITATIVE, URINE

    0 out of 5

    This assay is useful in detecting drug abuse to Barbiturates which are commonly used as “Downers” to induce sleep after Amphetamine or Cocaine induced “High”. As most Barbiturates are fast acting, their presence indicates use within the past 3 days except Phenobarbital which has a longer half life and its presence in urine indicates drug usage within the last 30 days.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • -13%
    Placeholder

    BENZODIAZEPINE SCREEN, QUALITATIVE, URINE

    0 out of 5
    800.00 700.00
  • Placeholder

    CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA, SCREEN, URINE

    0 out of 5

    The principal psychoactive cannabinoid is delta – 9 – tetrahydrocannabinol (THC) which is released slowly from tissue storage sites. Infrequent smokers may test positive for 2 to 5 days after last Marijuana / Hashish use; Chronic smokers may test positive even 3 to 4 weeks after abstinence. False positive result may be seen with Ketoconazole.

    • Test Type:

      Urine

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    CLOMIPRAMINE

    0 out of 5

    Clomipramine is a tricyclic antidepressant used primarily to treat Obsessive compulsive disorder (OCD). It is also used to treat Panic disorder and treatment resistant depression. This assay is useful in determining whether a poor therapeutic response is attributable to non compliance. It also assists in optimizing the administered dose.

    • Pre-test Information:

      Recommended specimen: >12 hours post oral dose.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    CLONAZEPAM

    0 out of 5

    Clonazepam is a long acting benzodiazepine restricted in use to those patients who no longer respond to Diazepam within non toxic levels. It is also effective in patients with Petit mal seizures who failed to respond to Succinimide therapy.

    • Pre-test Information:

      Recommended specimen: Before the administration of the next dose.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    CLORAZEPATE

    0 out of 5

    It is a common therapeutic drug of the diazepam group. Orally administered Clorazepate is rapidly decarboxylated to its metabolite Nordiazepam which has a half-life of 40-50 hours. Plasma levels of Nordiazepam increase proportionally with Clorazepate dose and show moderate accumulation with repeated administration.

    • Pre-test Information:

      Recommended specimen: Before the administration of the next dose.

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks